Net proceeds from the IPO are expected to total $57.6 million – or $66.7 million if underwriters exercise their full overallotment option of 1 .2 million shares...The immunotherapy firm expects to use net proceeds to fund R&D activities, including a request for orphan drug designation for ADSX-HPV in human papillomavirus-associated diseases, and for working capital and general corporate purposes

Gross proceeds totaled about $35 million, with net proceeds of $32.8 million to fund SFP clinical trials and for other general corporate purposes...The remainder of the net proceeds will be used for continued commercialization of its products, development of its product candidates and for general corporate purposes

Cosmo's net proceeds from the transaction will amount to about $85.9 million when the seller's commission and legal fees are deducted

Cosmo's net proceeds from the transaction will amount to about $85.9 million when the seller's commission and legal fees are deducted

Omeros Corp., of Seattle, said it closed the registered direct offering of 3.9 million shares of common stock priced at $4.14 per share, raising net proceeds of about $16.1 million

Net proceeds of about $13.2 million will be used primarily to support the commercial introduction of Surfaxin, its surfactant product approved last year for respiratory distress syndrome in premature infants, and the Afectair aerosol-conducting airway connector for infants, as well as for general corporate purposes...Net proceeds are expected to total about $16.1 million and will be used for general corporate purposes, including expenses related to the potential commercialization of OMS302 for

Net proceeds will be used primarily for working capital, R&D and general corporate purposes

Idera plans to use net proceeds for a Phase II trial with IMO-8400 in patients with psoriasis, and for working capital and general corporate purposes

Net proceeds of about $86.4 million will be used in part – $19.6 million – to repay in full the company's borrowings under and terminate its credit facility

Net proceeds will be used to support R&D activities, working capital and general corporate purposes...Insys, a specialty pharma firm developing supportive care products, expects net proceeds to support manufacturing, regulatory and working capital, as well as to repay outstanding debt

Net proceeds will be used to support R&D activities, working capital and general corporate purposes

Net proceeds will be used to fund ongoing operations

investor relations team in 2010 and meeting with a number of potential investors. (See BioWorld Today, March 20, 2013.) Net proceeds from the IPO are expected to total about $33.1 million – or $38.4 million if underwriters exercise their overallotment option in full

Net proceeds will be used to complete a Phase II Squalamine eye drop clinical trial for the wet form of age-related macular degeneration, to further the clinical development of the eye drops for the treatment of other neovascular ophthalmic disorders, to fund development of other pipeline molecules, and for general corporate purposes

investor relations team in 2010 and meeting with a number of potential investors. (See BioWorld Today, March 20, 2013.) Net proceeds from the IPO are expected to total about $33

12, for net proceeds of approximately $9.9 million

The offering is expected to close in April, with MIFSA retaining a portion of the net proceeds for general corporate purposes and Covidien retaining the majority of proceeds

The offering is expected to close in April, with MIFSA retaining a portion of the net proceeds for general corporate purposes and Covidien retaining the majority of proceeds

Most of the net proceeds from the proposed IPO would go toward advancing those two compounds, though Receptos said it might also in-license additional programs...Net proceeds will be used for general corporate purposes